Corcept Therapeutics CORT Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Corcept Therapeutics's deferred taxes?
- Corcept Therapeutics (CORT) reported deferred taxes of -$13.11M in Q1 2026.
- How has Corcept Therapeutics's deferred taxes changed year-over-year?
- Corcept Therapeutics's deferred taxes increased by 4.3% year-over-year, from -$13.71M to -$13.11M.
- What is the long-term trend for Corcept Therapeutics's deferred taxes?
- Over 3 years (2021 to 2024), Corcept Therapeutics's deferred taxes has grown at a 109.9% compound annual growth rate (CAGR), from $4.35M to -$40.19M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.